COMMUNIQUÉS West-GlobeNewswire

Pacific Biosciences of California, Inc. Announces Pricing of Public Offering of Common Stock

13/02/2018 - 15:00

MENLO PARK, Calif., Feb. 13, 2018 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ: PACB ) (the “Company”) today announced that it has priced its previously announced underwritten public offering of [...]

Catalyst Biosciences Announces Pricing of Public Offering of Common Stock

13/02/2018 - 14:46

SOUTH SAN FRANCISCO, Calif., Feb. 13, 2018 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (NASDAQ: CBIO ), a clinical-stage biopharmaceutical company focused on developing novel medicines to address hematology [...]

Teladoc to Announce Fourth Quarter and Full-Year 2017 Financial Results

13/02/2018 - 14:35

PURCHASE, NY, Feb. 13, 2018 (GLOBE NEWSWIRE) -- Teladoc , Inc. (NYSE: TDOC ), the world’s largest and most trusted provider of virtual care delivery services, announced today that it will release fourth quarter and full [...]

Microbot Medical’s CEO to Speak as an Industry Expert at the YJP CEO Healthcare Symposium

13/02/2018 - 14:30

HINGHAM, Mass., Feb. 13, 2018 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (NASDAQ: MBOT ), a medical device company specializing in the design and development of transformational micro-robotic medical technologies, today [...]

DBV Technologies : Monthly information regarding the total number of voting rights and total number of shares of the Company

13/02/2018 - 14:17

Monthly information regarding the total number of voting rights and total number of shares of the Company (Article 223-16 of the General Regulations of the Autorité des Marchés Financiers ) Market : NYSE Euronext Paris [...]

DBV Technologies : Information mensuelle relative au nombre total des droits de vote et d'actions composant le capital social

13/02/2018 - 14:17

Information mensuelle relative au nombre total des droits de vote et d'actions composant le capital social (Article 223-16 du Règlement Général de l'Autorité des Marchés Financiers) Place de cotation : NYSE Euronext [...]

Trading in Novo Nordisk shares by board members, executives and associated persons on 12 February 2018

13/02/2018 - 14:11

Bagsværd, Denmark, 13 February 2018 - This document discloses the data of the transaction(s) made in Novo Nordisk shares by the company's board members, executives and their associated persons in accordance with Article [...]

Novan to Present Integrated Data from Phase 3 Trials with SB204 for Treatment of Acne

13/02/2018 - 14:05

MORRISVILLE, N.C., Feb. 13, 2018 (GLOBE NEWSWIRE) -- Novan, Inc. ("the Company" or "Novan") (NASDAQ: NOVN ) today announced that data from the Company’s two Phase 3 clinical trials and long-term safety trial with SB204 [...]

Achaogen to Host Conference Call and Webcast of Fourth Quarter and Year 2017 Financial Results on February 27, 2018

13/02/2018 - 14:01

SOUTH SAN FRANCISCO, Calif., Feb. 13, 2018 (GLOBE NEWSWIRE) -- Achaogen, Inc. (NASDAQ: AKAO ), a late-stage biopharmaceutical company discovering and developing innovative antibacterials addressing multi-drug resistant [...]

BioSig Technologies to Open Operations Center in Austin, Texas

13/02/2018 - 14:00

Santa Monica, CA, Feb. 13, 2018 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to address an unmet [...]

Fulgent Genetics to Announce Fourth Quarter and Full Year 2017 Financial Results on February 28, 2018

13/02/2018 - 14:00

TEMPLE CITY, Calif., Feb. 13, 2018 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (NASDAQ: FLGT ) (“Fulgent Genetics” or the “company”) today announced that it will release its fourth quarter and full year 2017 financial [...]

Athletes vs Epilepsy Ambassador and Pro Golfer Jeff Klauk to Host Two Charity Tournaments Benefitting Epilepsy

13/02/2018 - 14:00

LANDOVER, Md., Feb. 13, 2018 (GLOBE NEWSWIRE) -- Don’t miss your shot to tee up with professional golfer Jeff Klauk as he hosts two Athletes vs Epilepsy Million Dollar Shootout golf tournaments this spring. The two [...]

Foamix Pharmaceuticals Fourth Quarter and Fiscal Year 2017 Financial Results Conference Call & Webcast Scheduled for February 28

13/02/2018 - 14:00

REHOVOT, Israel, and BRIDGEWATER, N.J., Feb. 13, 2018 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (NASDAQ: FOMX ), (“Foamix”), a clinical stage specialty pharmaceutical company focused on developing and [...]

Athenex Announces Recent Product Launches in 503B and Specialty Injectables Business Units

13/02/2018 - 14:00

BUFFALO, N.Y., Feb. 13, 2018 (GLOBE NEWSWIRE) -- Athenex, Inc. (Nasdaq: ATNX ), a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of [...]

The Celiac Disease Foundation Appoints New Member to Board of Directors

13/02/2018 - 14:00

LOS ANGELES, Feb. 13, 2018 (GLOBE NEWSWIRE) -- The Celiac Disease Foundation, the nation’s leading disease advocacy organization for celiac disease, announces the appointment of a new member to its Board of Directors. [...]

Nu-Med Plus Announces Keith L. Merrell as their full-time Chief Financial Officer and Secretary/Treasurer

13/02/2018 - 14:00

SALT LAKE CITY, Feb. 13, 2018 (GLOBE NEWSWIRE) -- Nu-Med Plus, Inc. (OTCBB: NUMD ), a medical device company which explores and develops medical applications of new disruptive technologies in the medical field, [...]

Progressive Care Breaks Record with Over 23,000 Prescriptions Filled in January 2018

13/02/2018 - 14:00

MIAMI, Feb. 13, 2018 (GLOBE NEWSWIRE) -- Progressive Care Inc. (OTCQB:RXMD), a healthcare services and technology company, announces record breaking month of January 2018. PharmCo, LLC filled over 23,000 prescriptions [...]

Pain Therapeutics Resubmits New Drug Application for REMOXY® ER, an Abuse-Deterrent, Extended-Release Drug Candidate for the Treatment of Chronic Pain

13/02/2018 - 14:00

AUSTIN, Texas, Feb. 13, 2018 (GLOBE NEWSWIRE) -- Pain Therapeutics, Inc. (Nasdaq: PTIE ) announced today the resubmission to the U.S. Food and Drug Administration (FDA) of a New Drug Application (NDA) for REMOXY ® ER, [...]

Tyme to Present at RBC Capital Markets 2018 Global Healthcare Conference

13/02/2018 - 14:00

NEW YORK, Feb. 13, 2018 (GLOBE NEWSWIRE) -- Tyme Technologies, Inc. (NASDAQ: TYME ), a clinical-stage biotechnology company developing cancer therapeutics, today announced that company management will present at the RBC [...]